AI assistant
HAEMONETICS CORP — Regulatory Filings 2021
May 28, 2021
31565_rns_2021-05-28_8380d7d1-f2f7-4377-9e99-196c07d90b4b.zip
Regulatory Filings
Open in viewerOpens in your device viewer
SD 1 formsdmay282021.htm SD html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd" Document created using Wdesk Copyright 2021 Workiva Document
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM SD
SPECIALIZED DISCLOSURE REPORT
HAEMONETICS CORPORATION
(Exact name of registrant as specified in its charter)
| Massachusetts | 001-14041 | 04-2882273 |
|---|---|---|
| (State or other jurisdiction of incorporation or organization) | (Commission File Number) | (I.R.S. Employer Identification No.) |
| 125 Summer Street, Boston, MA | 02110 |
|---|---|
| (Address of principal executive offices) | (Zip Code) |
| William P. Burke Executive Vice President, Chief Financial Officer (781) 848-7100 |
|---|
| (Name and telephone number, including area code, of the person to contact in connection with this report) |
| Check the appropriate box to indicate the rule pursuant to which this form is being filed, and provide the period to which the information in this form applies: | |
|---|---|
| ☒ | Rule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2020. |
SECTION 1 - Conflict Minerals Disclosure
Item 1.01 Conflict Minerals Disclosure and Report
Pursuant to Rule 13p-1 promulgated under the Securities Exchange Act of 1934, as amended, Haemonetics Corporation (the “Company”) has filed this Form SD for the reporting period from January 1, 2020 to December 31, 2020.
A copy of the Company’s Conflict Minerals Report is provided as Exhibit 1.01 to this Form SD and is publicly available at http://www.haemonetics.com/about-us/corporate-responsibility/our-products/conflict-minerals-statement.
Item 1.02 Exhibit
Item 2.01 of this Form SD is incorporated by reference into this Item 1.02.
SECTION 2 - Exhibits
Item 2.01 Exhibits
(a) Exhibits
| Exhibit Number | Description |
|---|---|
| 1.01 | Conflict Minerals Report of Haemonetics Corporation |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| HAEMONETICS CORPORATION — By: | /s/ William P. Burke |
|---|---|
| Name: | William P. Burke |
| Title: | Executive Vice President, Chief Financial Officer |